Trademark applications and grants for Apellis Pharmaceuticals Inc. Apellis Pharmaceuticals Inc has 21 trademark applications. The latest application filed is for "G.A.LLERY"
Patent Application | Date |
---|---|
COMPLEMENT INHIBITOR DOSING REGIMENS 20220280598 - 17/628084 Deschatelets; Pascal ;   et al. | 2022-09-08 |
VIRAL VECTOR THERAPY 20220249706 - 17/624755 Francois; Cedric ;   et al. | 2022-08-11 |
METHODS AND COMPOSITIONS FOR CANCER TREATMENT AND TREATMENT SELECTION 20220249663 - 17/480721 Francois; Cedric | 2022-08-11 |
COMPOSITIONS AND METHODS RELATING TO C5L2 20220088131 - 17/355029 Kemper; Claudia ;   et al. | 2022-03-24 |
METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS 20220040254 - 17/235281 Francois; Cedric ;   et al. | 2022-02-10 |
NCAGE Code | 5XS18 | APELLIS PHARMACEUTICALS, INC. |
CAGE Code | 5XS18 | APELLIS PHARMACEUTICALS, INC. |
SEC | 0001492422 | Apellis Pharmaceuticals, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.